Dr. Rubens C. Costa-Filho is an accomplished physician–scientist whose career spans decades of leadership, research, and academic contribution in the fields of intensive care, sepsis, hemostasis, thrombosis, and infectious diseases. His professional trajectory reflects a deep commitment to developing evidence-based practices, advancing critical care medicine, and contributing to scientific understanding through both clinical innovation and academic inquiry. His extensive experience includes the founding and long-term coordination of a major intensive care service, where he played a key role in establishing advanced protocols for the management of critically ill patients, with a particular focus on cardiovascular emergencies, sepsis, and multi-system organ dysfunction. His involvement in the creation of the Latin American Institute of Sepsis marked an important milestone in the region’s coordinated response to sepsis, strengthening collaborative research efforts, promoting professional education, and generating scientific awareness about early diagnosis and effective clinical management. His experience directing a specialized thromboelastometry service further cemented his expertise in coagulation assessment, blood management, and the clinical application of hemostatic monitoring technologies in critical care settings. Through this work, he contributed to improving transfusion practices, guiding therapeutic decision-making, and enhancing clinical outcomes in complex surgical and critically ill patient populations. Dr. Costa-Filho’s academic influence also extends to scientific communication and knowledge dissemination. He has been instrumental in designing educational platforms that connect healthcare professionals with leading experts, fostering interdisciplinary dialogue and expanding access to advanced medical knowledge. His commitment to academic development is additionally reflected in his participation in multidisciplinary research groups and continuous engagement with innovations in intensive care medicine, infectious disease epidemiology, and emerging therapeutic strategies. His longstanding involvement with global professional societies has allowed him to contribute to international guidelines, strengthen collaborative networks, and uphold high scientific standards in his fields of expertise. Currently, Dr. Costa-Filho is pursuing doctoral research in Tropical Medicine, expanding his scientific focus to infectious diseases that pose significant global health challenges. His Ph.D. work centers on COVID-19 within the Department of Tropical Medicine, where he contributes to ongoing investigations into immunological and pathophysiological mechanisms of the disease. Working in an immunopharmacology laboratory, he participates in studies examining host responses, inflammatory pathways, and potential therapeutic targets, with the aim of generating translational insights relevant to the management of severe viral infections.
Featured Publications
Price, V. L., Nanayakkara, A., Pasini, A., Bazellières, E., Vernale, A., Rocher, C., Borchiellini, C., Le Bivic, A., Renard, E., & Leys, S. P. (2025). Why homoscleromorph sponges have ciliated epithelia: Evidence for an ancestral role in mucociliary driven particle flux. Journal of Experimental Zoology Part B: Molecular and Developmental Evolution. Advance online publication.
Costa-Filho, R. C., Oliveira, A., Jr., Saddy, F., Costa, J. L. F., Azevedo, M. S., Cerqueira, D. F., Gualberto, V. H. A., Barbosa, M. I. N. H., Da-Cruz, A. M., & Horta, M. A. (2025). Evaluating the effectiveness of NOACs and LMWH in reducing mortality in critically ill patients with COVID‐19. Journal of Medical Virology. Advance online publication.
Costa-Filho, R. C., Leite, J. P. G., Horta, M. A., Naveca, F. G., Saddy, F., & Castro de Faria Neto, H. C. (2025). Commentary: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: A longitudinal study for medium and long term. Frontiers in Medicine, 12, 1558264.
Costa Silva, M., Costa, R. C., Filho, & Estato, V. (2025). Strategic use of intravenous medications to protect target organs in hypertensive emergencies. International Journal of Cardiovascular Sciences, 38(1).
Costa-Filho, R. C., Saddy, F., Costa, J. L. F., & Castro Faria Neto, H. C. (2025). The silent threat of human metapneumovirus: Clinical challenges and diagnostic insights from a severe pneumonia case. Microorganisms, 13(1), 73.
Costa-Filho, R. C. (2023). ISTH 2023 | XXXI Congress of the International Society on Thrombosis and Haemostasis. Event Participation.
Costa-Filho, R. C. (2023). PB0073 A retrospective study of two anticoagulation therapies in critically ill COVID-19 patients prior to vaccination era. Conference Poster, ISTH 2023.
Costa-Filho, R., Oliveira, A., Furtado, E., Saddy, F., de Souza, R., Azevedo, M., Cerqueira, D., Gualberto, V., Costa, J., & Castro-Faria-Neto, H. (2023). PB0073 A retrospective study of two anticoagulation therapies in critically ill COVID-19 patients prior to vaccination era. Research and Practice in Thrombosis and Haemostasis, 7(10), 100888.
Naveca, F. G., Nascimento, V. A., Nascimento, F., Ogrzewalska, M., Pauvolid-Corrêa, A., Araújo, M. F., Arantes, I., Batista, É. R., Magalhães, A. Á., & Vinhal, F. et al. (2023). SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil. Scientific Reports, 13, 33443.